Simon Buckingham
Directeur/Membre du Conseil chez Vaxxilon AG
Profil
Simon H.
W.
Buckingham is a professional with a doctorate degree from the University of Melbourne and an undergraduate degree from The University of Sydney.
He also attended the Australian Graduate School of Management.
Currently, he holds two non-executive director positions at Vaxxilon AG and Can Too Foundation.
In the past, he served as the President of Actelion Pharmaceuticals US, Inc. and Actelion Ltd.
He was also the Director of Actelion Pharmaceuticals Australia Pty Ltd.
Additionally, he served as a Director-Global Project at F.
Hoffmann-La Roche Ltd.
and Manager-Product Marketing & Territory at F.
Hoffmann La-Roche (Australia).
He was a Non-Executive Director at Syntara Ltd., Anteris Technologies Ltd., and Melodiol Global Health Ltd.
Postes actifs de Simon Buckingham
| Sociétés | Poste | Début |
|---|---|---|
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Directeur/Membre du Conseil | - |
| Can Too Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Simon Buckingham
| Sociétés | Poste | Fin |
|---|---|---|
| SYNTARA LIMITED | Directeur/Membre du Conseil | 22/11/2018 |
| ANTERIS TECHNOLOGIES LTD | Directeur/Membre du Conseil | 04/10/2018 |
| MELODIOL GLOBAL HEALTH LIMITED | Directeur/Membre du Conseil | 05/05/2017 |
| ACTELION | Corporate Officer/Principal | 01/01/2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | President | 01/01/2005 |
Formation de Simon Buckingham
| University of Melbourne | Doctorate Degree |
| The University of Sydney | Undergraduate Degree |
| Australian Graduate School of Management | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SYNTARA LIMITED | Health Technology |
| ANTERIS TECHNOLOGIES LTD | Health Technology |
| MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
| Entreprise privées | 7 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
| F. Hoffmann La-Roche (Australia) | |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Health Technology |
| Can Too Foundation | |
| Actelion Pharmaceuticals Australia Pty Ltd. |
